Spots Global Cancer Trial Database for Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
Official Title: A Randomised Double-blind Parallel-group Study to Evaluate the Long-term Effects of Eryfotona AK-NMSC® Cream in the Treatment of Cancerization Field in Patients With Actinic Keratosis.
Study ID: NCT01656226
Conditions
Study Description
Brief Summary: The purpose of this study is to assess the efficacy, safety and tolerability of Eryfotona AK-NMSC® topical application vs Sunscreen on cancerization field of actinic keratosis patients after 6 months of treatment.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Dermatology Unit, Medical Department Arcispedale Santa Maria Nuova, Reggio Emilia, , Italy
Contact Details
Name: Dr. Giuseppe Argenziano,, MD, PhD
Affiliation: Dermatology Unit, Medical Department /Arcispedale Santa Maria Nuova /Reggio Emilia, Italy
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
